key: cord-1044044-aiqkh258
authors: Ben‐Yakov, Maxim; James, Vigil
title: Young man with a diffuse rash and red eyes after recovery from COVID‐2019
date: 2021-03-23
journal: J Am Coll Emerg Physicians Open
DOI: 10.1002/emp2.12404
sha: 6abed107ead87eb520b5eba05469137546737c3b
doc_id: 1044044
cord_uid: aiqkh258

nan

A previously healthy 24-year-old male of East Asian descent pre- Intravenous immunoglobulin, steroids, and the interleukin-6 inhibitor tocilizumab have been used to treat suspected MIS-A cases, with clinical improvement noted in some instances. 2, 3 In our case, the patient was admitted to cardiology, his hsTrop declined, his transthoracic echocardiogram revealed mildly diminished left ventricular function (40%), and after consultation with the rheumatology service and a review with a pediatric rheumatologist from our regional referral center, the treating team initiated pulsed-dose steroids and a course of intravenous immunoglobulin. After a 5day admission and improvement in his hemodynamics, rash, and conjunctivitis, the patient was discharged with a tapered course of prednisone.

Maxim Ben-Yakov MDCM, FRCPC https://orcid.org/0000-0003-1057-3630

Multisystem inflammatory syndrome in adults: coming into focus

Coronavirus disease 2019 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units

Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection -United Kingdom and United States

Young man with a diffuse rash and red eyes after recovery from COVID-2019